Exhibit 1.1
ALLSTATE LIFE GLOBAL FUNDING
$5,000,000,000
SECURED MEDIUM TERM NOTE PROGRAM
DISTRIBUTION AGREEMENT
[
], 2006
Merrill Lynch, Pierce, Fenner & Smith
Incorporated
A.G. Edwards & Sons, Inc.
Banc of America Securities LLC
Barclays Capital Inc.
Bear, Stearns & Co. Inc.
Citigroup Global Markets Inc.
Credit Suisse Securities (USA) LLC
Deutsche Bank Securities Inc.
Goldman, Sachs & Co.
Greenwich Capital Markets, Inc.
J.P. Morgan Securities Inc.
Lehman Brothers Inc.
Morgan Stanley & Co. Incorporated
UBS Securities LLC
Wachovia Capital Markets, LLC
Ladies and Gentlemen:
Allstate Life
Global Funding, a Delaware statutory trust ("Global
Funding"), formed
pursuant to a Trust Agreement, dated June 24, 2002, as
amended, restated
or modified
from time to time (the
"Global Funding Trust
Agreement"), between
Wilmington Trust Company, as Delaware trustee (the "Global
Funding Delaware Trustee"), and AMACAR Pacific Corp., as trust
beneficial owner,
in connection with the
Allstate Life Global
Funding Secured
Medium Term Note
Program (the
"Institutional
Program") and the
Allstate Life(R)
CoreNotes(R)
Program (the "Retail Program" and, together with the Institutional
Program, the
"Programs"), confirms
its agreement with Merrill Lynch, Pierce, Fenner & Smith
Incorporated and each
other institution
named on Schedule 1
hereto (each, an
"Agent") with respect
to the issue and sale,
from time to time by separate and
distinct Delaware
statutory trusts formed and beneficially owned by Global
Funding (each, an "Issuing Trust" and, collectively, the "Issuing Trusts"), of
notes due between nine
months and thirty
years from the date of issuance (the
"Notes"). As of the
date
------------------------
Allstate Life(R) is a registered service mark of Allstate Insurance
Company.
CoreNotes(R) is a registered service mark of Merrill Lynch &
Co.
<PAGE>
hereof, the Issuing
Trusts are
authorized
to issue collectively up to U.S.
$5,000,000,000
aggregate initial
offering price of Notes (or its equivalent as
determined in Section 4(s)).
From
time to time, upon the formation of a new Issuing Trust, in
connection
with the offer and
sale of Notes by such
Issuing Trust,
upon execution and
delivery by such Issuing Trust and the applicable Agent or Agents of the terms
agreement (the "Terms
Agreement") set forth in Part E of the series instrument
to be executed by Global Funding, such Issuing Trust and the
applicable Agent or
Agents, among others (the "Series Instrument"), such Issuing Trust shall
become
a party hereto in relation to its Notes (the time of such execution
and delivery
referred to herein as such Issuing Trust's "Trust Effective Time"),
with all the
authority, rights,
powers, duties and obligations of an Issuing Trust as if
originally named
as an Issuing Trust hereunder. Any agreement, covenant,
acknowledgment,
representation or
warranty made by an Issuing Trust hereunder
shall be deemed to have been made by each Issuing Trust at its Trust Effective
Time and at the Applicable Time (as defined in the applicable
Terms Agreement
for such Issuing Trust, the "Applicable Time") unless another time or
times are
specified herein,
in which case such
specified time or times shall instead
apply.
The
Notes of each Issuing Trust will be issued pursuant to an
indenture, as
amended or modified
from time to time,
which will adopt and
incorporate
the
standard
indenture terms
(each, an "Indenture" and, collectively, the
"Indentures") between
the relevant Issuing Trust and J.P. Morgan Trust Company,
National Association,
as indenture
trustee (the
"Indenture
Trustee").
Each
Issuing Trust shall issue only one series of Notes.
Each
Issuing Trust will
immediately use the
proceeds from the sale of its
Notes to purchase a funding note (each a "Funding Note") from Global Funding.
Each Funding
Note will be issued
pursuant to a funding note indenture, as
amended or modified
from time to time,
which will adopt and
incorporate
the
standard funding note indenture terms (each, a "Funding Note
Indenture") between
Global Funding and
J.P. Morgan Trust
Company, National Association, as the
funding note indenture
trustee (the "Funding Note Indenture Trustee"). Global
Funding will
immediately
use the net proceeds
received from the sale of the
Funding Note
to purchase one or more funding agreements (the "Funding
Agreement(s)") issued by Allstate Life Insurance Company, an
Illinois stock life
insurance company
(the "Company"). Global Funding will immediately assign
absolutely to, and deposit into the relevant Issuing Trust, the
relevant Funding
Agreement(s) and the relevant Funding Note will be surrendered. The
Notes of the
Issuing Trust will be secured by the relevant Funding Agreement(s).
The Issuing
Trust will immediately collaterally assign, and grant a first
priority perfected
security interest in, the Funding Agreement(s) to the Indenture
Trustee for the
benefit of the holders of the Notes of the Issuing Trust pursuant to the terms
of the Indenture. In
connection with the
sale of its Notes, the
Issuing Trust
will prepare a Pricing
Supplement
(the "Pricing Supplement") including or
incorporating by reference a description of the terms of the Notes
and the terms
of the offering.
The
Agents include those institutions named from time to time in
Schedule 1
hereto and any
institution appointed
as an Agent pursuant to Section 20 below.
If any institution is
appointed as an Agent only with respect to the Notes of a
particular Issuing
Trust, such
institution shall only be an Agent with respect
to Notes of such Issuing Trust.
2
<PAGE>
This
Agreement specifies the terms and conditions on which Notes may
be
sold by an Issuing
Trust (i) to one or more Agents as principal for resale to
investors, (ii)
directly to investors
through the applicable Agent as an agent
of such Issuing Trust in soliciting offers for the purchase of Notes
and (iii)
to such other
investors in compliance with all applicable securities laws as
such Issuing Trust may determine from time to time.
The
Company has registered
shares of its common
stock with the Securities
and Exchange
Commission (the
"Commission")
pursuant to Section
12(g) of the
Securities Exchange
Act of 1934, as amended (the "1934 Act"), on Form 10 under
the 1934 Act. Pursuant to Rule 429 of the rules and regulations of the
Commission under
the Securities Act of 1933, as amended (the "1933 Act
Regulations"), the Company and Global Funding have filed with the
Commission (i)
a registration
statement on Form S-3 (No. 333-129157) and pre-effective
amendment No. 1 thereto under the Securities Act of 1933, as amended
(the "1933
Act"), for the registration of the Funding Agreement(s),
the Funding Notes,
and
the Notes, and the
offering thereof in accordance with Rule 415 of the 1933 Act
Regulations; (ii) the
related prospectus
dated [ ], 2006
covering the Notes
offered under the
Programs (the "Base Prospectus"); (iii) the prospectus
supplement to the Base Prospectus, dated [ ], 2006, covering the Notes offered
under the Institutional Program (the "Institutional Prospectus Supplement" and
together with the Base Prospectus, the "Institutional Base Prospectus"); and
(iv) the prospectus supplement to the Base Prospectus, dated [ ],
2006, covering
the Notes offered under the Retail Program (the "Retail
Prospectus
Supplement"
and, together with the
Base Prospectus,
the "Retail Base
Prospectus").
Such
registration statement
(as so amended, if applicable), is also the first
post-effective
amendment to registration statement on Form S-3 (No.
333-125937)
filed by the Company and Global Funding. The registration
statement on Form
S-3
(No. 333-129157) (as
so amended, if
applicable) has been declared effective by
the Commission, and the form of Indenture and the form of Funding
Note Indenture
have been duly qualified under the Trust Indenture Act of
1939, as amended (the
"1939 Act"), and the
Company and Global Funding have filed such post-effective
amendments thereto as
may be required prior to the acceptance by Global Funding
and any Issuing
Trust of any
offer for the purchase of Notes and each such
post-effective
amendment has been declared effective by the Commission. Such
registration statement
on Form S-3 (No.
333-129157),
at any relevant time,
including the
amendments thereto to
such time, the
exhibits and any schedules
thereto at such time, the documents incorporated by reference
therein pursuant
to Item 12 of Form S-3
under the 1933 Act at such time and the documents
otherwise deemed
to be a part
thereof or included therein by the 1933 Act
Regulations is
referred to herein as the "Registration Statement". If the
Company or Global
Funding file a
registration statement
with the Commission
pursuant to
Rule 462(b) of the 1933 Act Regulations (the "Rule 462(b)
Registration
Statement"), then,
after such filing, all references to the
"Registration
Statement" shall
also be deemed to include the Rule 462(b)
Registration Statement. With respect to the offering of a
series of Notes under
the Institutional
Program, the Institutional Base Prospectus, and with respect
to the offering of a series of Notes under the Retail Program, the Retail Base
Prospectus, in each
case including
the Pricing Supplement relating to the
offering of such
series of Notes, in
the form first filed with the Commission
pursuant to Rule 424(b) of the 1933 Act Regulations (or in the form first made
available to the applicable Agent(s) by the Company and the
applicable Issuing
Trust to meet requests
of purchasers pursuant to Rule 173 under the
1933 Act
Regulations), are
referred to herein as the "Prospectus." The term "preliminary
prospectus" means any
preliminary form of
the Prospectus. For
all purposes of
this Agreement, the
term "free writing prospectus" has
3
<PAGE>
the meaning set forth
in Rule 405 under the 1933 Act Regulations and the term
"Time of Sale
Prospectus" means (i)
with respect to the
offer and sale of any
series of Notes under the Institutional Program, the Institutional Base
Prospectus and (ii)
with respect
to the offer and sale
of any series of Notes
under the Retail Program, the Retail Base Prospectus in each
case as amended or
supplemented from time to time, together with any other
preliminary
prospectus
relating to the offer and sale of such series of Notes,
any Pricing
Supplement
relating to the offer and sale of such series of Notes filed with
the Commission
prior to the
Applicable Time and
each free writing
prospectus (including
any
final term sheet
relating to such series of Notes) attached as, or identified
in, Exhibit A to the
applicable
Terms Agreement and any other information
identified in Exhibit A to the applicable Terms Agreement. All
references to the
"Registration Statement", the "Institutional Base Prospectus",
the "Retail Base
Prospectus", any "preliminary prospectus", the "Time of Sale
Prospectus" and the
"Prospectus" shall
also be deemed to include all amendments and supplements
thereto and all documents incorporated by reference therein. For purposes of
this Agreement,
all references to the Registration Statement, Time of Sale
Prospectus,
Prospectus, any
preliminary prospectus or free writing prospectus,
or to any amendment or
supplement
thereto shall be
deemed to include any copy
filed with the Commission pursuant to its Electronic Data
Gathering,
Analysis
and Retrieval system ("EDGAR").
All
references in this Agreement to financial statements and schedules and
other information which is "disclosed", "contained", "included" or
"stated" (or
other references of
like import) in the
Registration
Statement, Time of
Sale
Prospectus,
Prospectus, any
preliminary prospectus
or free writing prospectus
shall be deemed to include all such financial statements and
schedules and other
information which is
incorporated
by reference in or
otherwise deemed by
the
1933 Act Regulations to be a part of or included in the
Registration
Statement,
Time of Sale Prospectus, Prospectus, any preliminary
prospectus or free writing
prospectus, as the
case may be; and all references in this Agreement to
amendments or
supplements
to the Registration Statement, Time of Sale
Prospectus,
Institutional Base Prospectus, Retail Base Prospectus, Prospectus,
any preliminary prospectus or free writing prospectus shall be
deemed to include
all documents
subsequently filed
with the Commission
pursuant to the 1934 Act
which are incorporated
by reference in or otherwise deemed by the 1933 Act
Regulations to be part
of or included in the
Registration
Statement, Time of
Sale Prospectus,
Institutional
Base Prospectus, Retail Base Prospectus,
Prospectus, any
preliminary prospectus or free writing prospectus, as the case
may be.
SECTION 1. Appointment as Agent.
(a)
Appointment. Subject
to the terms and conditions stated herein, Global
Funding and the
relevant Issuing Trust hereby agree that the Notes of such
Issuing Trust will be
sold to or through the
Agents pursuant
to the terms of
this Agreement.
Global Funding and the
relevant Issuing Trust
agree that they
will not appoint
any other agents to act on an Issuing
Trust's behalf or to
assist an Issuing Trust, in the placement of the Notes;
provided, however that
with respect to
transactions
in which the sales of
Notes will be targeted
to
institutional
purchasers under the Institutional Program, Global Funding and
an
Issuing Trust may
enter into
arrangements with
other agent(s) not a
party to
this Agreement
provided that such
agent(s) enter into an
agreement with terms
substantially
identical to those
contained herein. Global Funding and each
Issuing Trust agree that they hereby appoint only Merrill Lynch,
Pierce, Fenner
& Smith
Incorporated
4
<PAGE>
(the "Purchasing
Agent") to act on an
Issuing Trust's
behalf or to assist
an
Issuing Trust in connection with transactions in which the sale of
Notes will be
targeted to retail
purchasers under the
Retail Program.
For purposes of
this
Agreement, all references to any Agent shall be deemed to include
the Purchasing
Agent.
(b)
Sale of Notes.
Each Issuing Trust shall not sell or approve the
solicitation of offers
for the purchase of Notes in excess of the
aggregate
initial offering
price of Notes registered pursuant to the Registration
Statement. The Agents
shall have no responsibility for maintaining records with
respect to the aggregate initial offering price of Notes sold, or
of otherwise
monitoring the availability of Notes for sale, under the
Registration Statement.
(c)
Purchases as
Principal.
The Agents shall not
have any obligation
to
purchase Notes issued through any Issuing Trust as principal.
However, absent an
agreement by and between Global Funding and the relevant
Issuing Trust,
on the
one hand, and an Agent, on the other hand, for such Agent to act as
an agent for
the relevant Issuing Trust, such Agent shall be deemed to be acting
as principal
in connection with any offering of Notes by such Issuing Trust.
Accordingly, the
Agents, individually
or in a syndicate, may agree from time to time to purchase
Notes from an Issuing Trust as principal for resale to investors
determined by
such Agents.
Any purchase of Notes from an Issuing Trust by an Agent as
principal shall be made in accordance with Section 3(a) hereof.
(d)
Solicitations
as Agent. If agreed upon between an Agent,
on the one
hand, and Global
Funding and an Issuing
Trust, on the other hand, then such
Agent, acting
solely as an agent for
such Issuing Trust and
not as principal,
will solicit offers
for the purchase of Notes. Such Agent will communicate to
such Issuing Trust, orally, each offer for the purchase of Notes
solicited by it
on an agency basis
other than those offers rejected by such Agent.
Such Agent
shall have the right,
in its discretion
reasonably
exercised,
to reject any
offer for the purchase
of Notes, in whole or
in part, and any such
rejection
shall not be deemed a breach of its agreement contained herein. Such Issuing
Trust may accept or reject any offer for the purchase of Notes, in whole or in
part. Such Agent shall make reasonable efforts to assist such Issuing
Trust in
obtaining performance
by each purchaser
whose offer for the
purchase of Notes
has been solicited by
it on an agency basis and accepted by such Issuing Trust.
Such Agent shall not have any liability to such Issuing Trust in
the event that
any such purchase is not consummated for any reason. If such
Issuing Trust shall
default on its
obligation to deliver Notes to a purchaser whose offer has been
solicited by an Agent on an agency basis and accepted by such Issuing Trust,
then (i) such Issuing
Trust shall hold such
Agent harmless
against any loss,
claim or damage
arising from or as a
result of such default
by such Issuing
Trust and (ii) the Issuing Trust shall be responsible to pay to such Agent any
commission to which such Agent would otherwise be entitled absent
such default.
(e)
Reliance. Each Issuing
Trust and Global Funding, on the one hand, and
the Agents, on the
other hand, agree that
any Notes purchased
from an Issuing
Trust by one or more Agents as principal shall be purchased, and any Notes the
placement of which an Agent arranges as an agent of such
Issuing Trust shall be
placed by such Agent, in reliance on the representations,
warranties,
covenants
and agreements of Global Funding and such Issuing Trust contained
herein and on
the terms and conditions and in the manner provided herein.
5
<PAGE>
SECTION 2. Representations and Warranties.
(a)
Representations
and Warranties of Global Funding. Global Funding
represents and
warrants to each Agent as of the date hereof, to the applicable
Agent(s) as of the
Applicable
Time for the
relevant Issuing Trust, to the
applicable Agent(s) as
of the date of each
delivery of Notes
(whether to such
Agent as principal
or through such Agent as agent) (the date of each such
delivery is referred to herein as a "Settlement Date"), to each Agent as of
any
time the Time of Sale Prospectus shall be amended or supplemented and to each
Agent as of any time that the Registration Statement or the Prospectus shall
be
amended or
supplemented (each of
the times referenced
above is referred to
herein as a "Global Funding Representation Date"), as follows:
(i) Due Formation and Good Standing of Global Funding. Global Funding
is a
statutory trust, duly formed under Delaware law pursuant to the
Global
Funding Trust
Agreement and the filing of a certificate of trust with the
Delaware Secretary of State, which is validly existing and in good
standing
as a
statutory trust under the laws of the State of Delaware.
(ii) Registration Statement, Preliminary Prospectuses, Time of Sale
Prospectus, and
Prospectus;
Filing Status. Global Funding meets the
requirements for use
of Form S-3 under
the 1933 Act; the Registration
Statement has
become effective under the 1933 Act and no stop order
suspending the effectiveness of the Registration Statement has been issued
under the 1933 Act and
no proceedings for that purpose have been instituted
or
are pending or, to the knowledge of Global Funding, are contemplated by
the
Commission,
and any request on the part of the Commission for
additional information
has been complied
with; the form of
Indenture has
been
duly qualified under
the 1939 Act; the form of Funding Note Indenture
has
been duly qualified
under the 1939 Act; at the respective times that
each
part of the Registration Statement became effective and at each
Global
Funding Representation
Date, the Registration
Statement complied and will
comply in all material
respects with the
requirements of the 1933 Act and
the
1933 Act Regulations, the 1934 Act and the rules and regulations of
the
Commission under the 1934 Act (the "1934 Act Regulations") and the
1939 Act
and
the rules and
regulations of the
Commission
under the 1939 Act
(the
"1939 Act Regulations") and did not and will not contain an untrue
statement of a material fact or omit to state a material
fact required to
be
stated therein or necessary to make the statements therein not
misleading; each preliminary prospectus and Prospectus filed as
part of the
Registration Statement
as originally filed or as part of any
amendment
thereto, or filed
pursuant to Rule 424 under the 1933 Act Regulations,
complied when so filed
in all material
respects with the 1933 Act and the
1933
Act Regulations; each preliminary prospectus and the Prospectus
delivered to an Agent for use in connection with the offering of Notes are
identical in all material respects to any electronically
transmitted copies
thereof filed with the Commission pursuant to EDGAR, except to the extent
permitted by
Regulation S-T;
and at the date
hereof, at the date of
the
Base
Prospectus and each amendment or supplement thereto and at each
Global
Funding Representation
Date, neither the Base Prospectus nor any amendment
or
supplement
thereto included or will include an untrue
statement of a
material fact or omitted or will omit to state a material fact
necessary in
order to make the
statements therein,
in the light of the
circumstances
under which they were made, not misleading. The Time of Sale Prospectus
does
not, and at the Applicable
6
<PAGE>
Time
and at the applicable Settlement Date, the Time of Sale Prospectus,
as
then
amended or
supplemented by Global
Funding, if
applicable, will
not
contain any untrue statement of a material fact or omit to state a
material
fact
necessary to make the statements therein, in the light of the
circumstances under
which they were made, not misleading; provided,
however, that the
representations and
warranties in this subsection shall
not
apply to (i) statements in or omissions from the Registration
Statement, the
Base Prospectus, the Time of Sale Prospectus or the
Prospectus made
in reliance upon and in conformity with information
furnished to Global Funding in writing by the applicable
Agents concerning
such Agents expressly for use in the Registration Statement, the Base
Prospectus, the Time of Sale Prospectus or the Prospectus or (ii)
the parts
of
the Registration Statement which constitute the Statement of
Eligibility
and
Qualification (Form
T-1) of the Indenture Trustee and the Funding Note
Indenture Trustee under the 1939 Act.
(iii) Incorporated
Documents;
1934
Act Filings. The documents
incorporated or deemed
to be incorporated by reference in the Time of Sale
Prospectus or the Base Prospectus, as amended or supplemented,
at the time
they
were or hereafter
are filed with the
Commission,
complied and will
comply in all material
respects with the
requirements of the 1934 Act and
the
1934 Act Regulations and, when read together with the other
information
in
the Time of Sale Prospectus or the Base Prospectus, at the date hereof,
at
the date of the Time of Sale Prospectus or the Base
Prospectus
and at
each
Global Funding
Representation
Date, did not and will
not include an
untrue statement
of a material fact or omit to state a material fact
necessary in order to
make the statements
therein, in the light of the
circumstances under
which they were made,
not misleading.
Any reports,
filings or other
documents, exhibits or
schedules filed by Global Funding
and
each Issuing
Trust pursuant to the 1934 Act comply in all
material
respects with
the requirements of the 1934 Act and the 1934 Act
Regulations.
(iv) Free Writing
Prospectuses. At the
time of initial filing of the
Registration Statement, at the earliest time thereafter that Global
Funding
or
another offering
participant made a bona fide offer (within the meaning
of
Rule 164(h)(2)
of the 1933 Act
Regulations)
of any Notes and at
each
Global Funding
Representation Date,
Global Funding was not
and is not an
"ineligible issuer,"
as defined in Rule 405
of the 1933 Act
Regulations.
Any
free writing
prospectus
that Global Funding is required to file
pursuant to Rule 433(d) under the 1933 Act Regulations has been, or will
be,
filed with the Commission in accordance with the requirements of the
1933
Act and the 1933 Act
Regulations. Each free
writing prospectus
that
Global Funding has filed, or is required to file,
pursuant to Rule
433(d)
under the 1933 Act
Regulations or that
was prepared by or on behalf of or
used
by Global Funding
complies or will
comply in all material
respects
with
the requirements of the applicable 1933 Act Regulations. Except with
respect to
the offering of any series of Notes, the free writing
prospectuses
attached as, or
identified in,
Exhibit A to the
applicable
Terms Agreement,
Global Funding and the
Issuing Trusts have not prepared,
used
or referred
to, and will not, without the prior consent of the
applicable Agents, prepare, use or refer to, any free writing
prospectus or
any
other marketing materials other than the preliminary prospectus
relating to or to be
used in connection
with any offer or sale of the
Notes. No free writing prospectus used in
7
<PAGE>
connection with the offering of a series of Notes will conflict
with either
the
Registration Statement or the Base Prospectus.
(v) Independent Registered Public Accounting Firm. The accounting
firm
which certified
the financial
statements
and any supporting schedules
thereto included in the Registration Statement and the Base
Prospectus, as
amended or supplemented, is an independent registered public accounting
firm
to the extent required by the 1933 Act and the 1933 Act
Regulations.
(vi) Global Funding Financial Statements. The consolidated financial
statements of Global
Funding, if any, included in any report or filing
under the 1934 Act,
together with the related schedules and notes present
fairly the consolidated financial position of Global Funding at the
dates
indicated to the
extent required under the 1934 Act; such financial
statements have
been prepared in conformity with generally accepted
accounting principles ("GAAP") applied on a consistent basis
throughout the
periods involved;
the supporting schedules, if any, present fairly in
accordance with GAAP
the information
required to be stated
therein; the
selected financial data and the summary financial information included in
the
Registration Statement
and the Time of Sale Prospectus present fairly
the
information shown therein.
(vii) No Material
Changes. Since the respective dates as of which
information is given
in the Registration
Statement and the Time of Sale
Prospectus, except as otherwise stated therein, (1) there has been
no event
or
occurrence
that would result in a material adverse effect on the
condition (financial
or otherwise)
of Global Funding or on the power or
ability of Global Funding to perform its obligations under this Agreement,
the
Global Funding Trust Agreement, any Funding Note or the
Administrative
Services Agreement (the "Global Funding Administration Agreement"), dated
June
24, 2002, as amended,
restated or modified from time to time, between
the
Global Funding
Delaware Trustee, on behalf of Global Funding, and
AMACAR Pacific
Corp.,
as administrator
(the
"Global
Funding
Administrator"), or to consummate the transactions to be performed
by it as
contemplated in the
Time of Sale
Prospectus (a "Global
Funding Material
Adverse Effect") and
(2) there have been no
transactions entered
into by
Global Funding, other than those in the ordinary course of
business, which
are
material with respect to Global Funding.
(viii) Authorization
of this Agreement, each Funding Agreement, Global
Funding Trust
Agreement, Global
Funding Administration Agreement, the
Funding Note Indenture and the Funding Notes. This Agreement, the Global
Funding Trust
Agreement and Global Funding Administration Agreement have
been, and each Funding Note Indenture, Funding Note and relevant
Funding
Agreement will be,
duly authorized, executed and delivered by Global
Funding and this Agreement, each relevant Funding Agreement, the Global
Funding Trust Agreement, the Global Funding Administration
Agreement, the
Funding Note
Indenture and the Funding Notes will each be a valid and
legally binding
agreement of Global
Funding enforceable against Global
Funding in accordance with its terms, as applicable, except as enforcement
thereof may
be limited by bankruptcy, insolvency, reorganization,
moratorium or other similar laws affecting the enforcement of creditors'
rights generally or by general equitable principles (regardless
8
<PAGE>
of
whether enforcement is
considered in a proceeding in equity or at law),
and
except further as
enforcement thereof
may be limited by
requirements
that
a claim with respect
to any Funding Note that is payable in a foreign
or
composite currency (or a foreign or composite currency judgment in
respect of such claim) be converted into U.S. dollars at a rate of
exchange
prevailing on
a date determined pursuant to applicable law or by
governmental authority
to limit, delay or
prohibit the making of payments
outside the United States. The holder of the Funding Notes will be
entitled
to
the benefits of the Funding Note Indenture.
(ix) Absence of
Defaults and Conflicts. Global Funding is not in
violation of its
certificate of trust or in default in the performance or
observance of any obligation, agreement, covenant or condition
contained in
any
contract, indenture, mortgage, loan or credit agreement, note,
lease or
other agreement or
instrument
to which Global Funding is a party or by
which it may be bound or to which any of the property or assets of Global
Funding is subject
(the "Global
Funding Agreements and Instruments"),
except for such
violations or defaults
that would not result
in a Global
Funding Material
Adverse Effect; and the execution, delivery and
performance of this
Agreement,
the Global Funding
Trust Agreement,
the
Funding Agreement(s),
Global Funding Administration Agreement and each
Funding Note and any other agreement or instrument
entered into or
issued
or
to be entered into or issued by Global Funding in connection with the
transactions contemplated by the Time of Sale Prospectus
(collectively, the
"Global Funding Program Documents"), the consummation of the
transactions
contemplated in the
Time of Sale
Prospectus (including
the issuance and
sale
of the Notes by an Issuing Trust and the use of proceeds
therefrom as
described in the Time
of Sale Prospectus)
and the compliance by Global
Funding with its
obligations
hereunder and under
Global Funding
Program
Documents, have been duly authorized by all necessary action and do
not and
will
not, whether
with or without
the giving of notice
or the passage of
time
or both, conflict with
or constitute a breach of, or default or event
or
condition which gives the holder of any note, debenture or other
evidence of indebtedness (or any person acting on such holder's
behalf) the
right to require
the repurchase, redemption or repayment of all or a
portion of such
indebtedness by Global
Funding under, or result in the
creation or imposition of any lien, charge or encumbrance upon any
assets,
properties or operations of any Issuing Trust or Global
Funding pursuant
to,
any Global Funding
Agreements and
Instruments,
nor will such
action
result in any
violation of Global
Funding's certificate of trust, the
Global Funding Trust Agreement or Global Funding Administration Agreement
which may reasonably
be expected to result
in a Global Funding
Material
Adverse Effect and Global Funding is not in default in the
performance or
observance of any applicable law, statute, rule, regulation, judgment,
order, writ or decree
of any government,
government
instrumentality
or
court, domestic or foreign, having jurisdiction over Global
Funding or any
of
its assets, properties
or operations,
except for such
defaults which
would not reasonably be expected to result in a Global
Funding Material
Adverse Effect.
(x) Absence of
Proceedings.
There is no action,
suit, proceeding,
inquiry or
investigation before
or brought by any
court or
governmental
agency or body,
domestic or foreign,
now pending, or to the
knowledge of
Global Funding
threatened,
against or affecting
Global Funding which
is
required to be
disclosed in the Registration Statement and the Base
Prospectus, as amended
or supplemented (other than as stated therein), or
9
<PAGE>
which may reasonably
be expected to result
in a Global Funding
Material
Adverse Effect;
and the aggregate of all pending
legal or governmental
proceedings to which
Global Funding is a party or of which any of its
assets, properties or
operations is the subject which are not described in
the
Registration
Statement and the Base Prospectus, as amended or
supplemented,
including ordinary
routine litigation incidental to the
business, may not
reasonably
be expected
to result in a Global
Funding
Material Adverse Effect.
(xi) Possession of Licenses and Permits. Global Funding possesses
such
permits,
licenses,
approvals,
consents and
other
authorizations
(collectively,
"Governmental Licenses") issued by the appropriate federal,
state, local or foreign regulatory agencies or bodies necessary to
conduct
the
business now operated by it; Global Funding is in compliance
with the
terms and conditions of all such Governmental Licenses, except where the
failure so to comply
would not, singly or
in the aggregate,
result in a
Global Funding
Material Adverse Effect; all of the Governmental
Licenses
are
valid and in full force and effect, except where the invalidity of
such
Governmental Licenses or the failure of such Governmental Licenses
to be in
full force and effect
would not result in a Global Funding Material Adverse
Effect. Except as set forth in the Time of Sale Prospectus,
Global Funding
has
not received any notice of proceedings relating to the revocation or
modification of any
such Governmental
Licenses which, singly or in the
aggregate, if the
subject of an unfavorable decision, ruling or finding,
would result in a Global Funding Material Adverse Effect.
(xii) No Filings,
Regulatory
Approvals etc. No filing with, or
approval,
authorization,
consent, license,
registration,
qualification,
order or decree of, any court or governmental authority or agency,
domestic
or
foreign, is necessary
or required for the due authorization, execution
and
delivery by Global Funding of Global Funding Program Documents or for
the
performance
by Global Funding of the transactions contemplated in
Global Funding Program Documents, except such as have been
previously made,
obtained or rendered, as applicable.
(xiii) Investment
Company Act. Neither Global Funding nor any Issuing
Trust is, and upon any sale of Funding Notes and the Notes as herein
contemplated and the application of the net proceeds therefrom as
described
in
the Time of Sale Prospectus, will not be an "investment
company" within
the
meaning of the
Investment Company Act
of 1940, as amended
(the "1940
Act").
(xiv) Ratings.
The Programs are (A) expected to be rated Aa2 by
Moody's Investors Service, Inc. ("Moody's") and (B) rated AA
by Standard &
Poor's Ratings
Services, a division
of The McGraw-Hill
Companies,
Inc.
("Standard & Poor's") (Moody's and Standard & Poor's are
referred to herein
as
the "Ratings Agencies"), or, in each case, such other rating as to
which
Global Funding
shall have most
recently notified the
Agents pursuant to
Section 4(u) hereof.
(xv) Notes Listed on
any Stock Exchange.
If specified in a Pricing
Supplement, the Notes
described in such Pricing Supplement shall be listed
on
the securities exchange designated in the Pricing Supplement.
10
<PAGE>
(xvi) Relationship
between Global Funding and the Agents. Global
Funding acknowledges and agrees that (i) the purchase and sale of
the Notes
pursuant to this
Agreement, including
the determination
of the offering
price of the
Notes and any related discounts and commissions, is an
arm's-length
commercial transaction
between Global
Funding, on the one
hand, and the several
Agents, on the other
hand, (ii) in
connection with
the
offerings contemplated hereby and the process leading to such
transactions each Agent is and has been acting solely as a
principal and is
not
the agent or fiduciary of Global Funding, or its stockholders,
creditors, employees or any other party, (iii) no Agent has assumed
or will
assume an advisory or fiduciary responsibility in favor of Global Funding
with
respect to the offerings contemplated hereby or the process leading
thereto (irrespective
of whether
such Agent has advised
or is currently
advising Global
Funding on other
matters) and no Agent has any obligation
to
Global Funding with respect to the offerings contemplated hereby except
the
obligations expressly set forth in this Agreement, (iv) the Agents and
their respective affiliates may be engaged in a broad range of
transactions
that
involve interests that
differ from those of Global Funding, and (v)
the
Agents have not
provided any legal, accounting, regulatory or tax
advice with respect to the offerings contemplated hereby and Global
Funding
has
consulted its own legal, accounting, regulatory and tax advisors to
the
extent it deemed appropriate.
(b)
Representations
and Warranties of the
relevant Issuing
Trust. Each
Issuing Trust
represents and warrants, only as to itself, to each applicable
Agent as of the such Issuing Trust's Trust Effective Time, as
of its Applicable
Time and as of the date of each delivery of its Notes (whether to each such
Agent as principal
or through each such
Agent as agent) (the date of each such
delivery is
referred to herein as a "Settlement Date") (each of the times
referenced above is
referred to herein as an "Issuing Trust Representation
Date"), as follows:
(i) Due Formation and Good Standing of the Issuing Trust. Such
Issuing
Trust is a statutory trust, duly formed under Delaware law
pursuant to the
trust agreement between Wilmington Trust Company, as Delaware trustee (the
"Relevant Issuing
Trust Trustee") and
Global Funding (the
"Issuing Trust
Agreement") and the
filing of a
certificate of trust
with the Delaware
Secretary of State,
which is validly
existing and in good
standing as a
statutory trust under the laws of the State of Delaware.
(ii) No Material
Changes. Since the respective dates as of which
information is given
in the Registration
Statement and the Time of Sale
Prospectus or the
Trust Effective
Time, whichever is later, except as
otherwise stated
therein, (1) there has been no event or
occurrence that
would result in a material adverse effect on the condition
(financial or
otherwise) of such Issuing Trust or on the power or ability of such
Issuing
Trust to perform its obligations under this Agreement, the Issuing Trust
Agreement, its Notes,
any Funding Agreement,
the Indenture or the Issuing
Trust Administrative
Services Agreement (the "Issuing Trust Administration
Agreement"), as amended or modified from time to time, between the
Relevant
Issuing Trust Trustee,
on behalf of such Issuing Trust, and AMACAR Pacific
Corp., as administrator (the "Issuing Trust Administrator"), or to
consummate the
transactions to be
performed by it as
contemplated in the
Time
of Sale Prospectus (an
"Issuing Trust Material Adverse Effect") and
(2)
there have been no
transactions entered
into by such Issuing
Trust,
other
11
<PAGE>
than
those in the ordinary
course of business,
which are material with
respect to such Issuing Trust.
(iii) Authorization
of this Agreement,
the Issuing Trust
Agreement,
the
Issuing Trust
Administration
Agreement, the
Indenture and the Notes.
This
Agreement,
the Issuing Trust Agreement, the Issuing Trust
Administration
Agreement and the relevant Indenture have been or will
be,
duly
authorized,
executed and delivered
by such Issuing Trust and each is
or
will be a valid and
legally binding
agreement of the Issuing Trust
enforceable against
the Issuing Trust in
accordance
with its terms,
as
applicable, except as
enforcement
thereof may be limited
by bankruptcy,
insolvency, reorganization, moratorium or other similar laws
affecting the
enforcement of
creditors'
rights
generally or by general equitable
principles (regardless of whether enforcement is considered in a
proceeding
in
equity or at law), and
except further as
enforcement
thereof may be
limited by requirements that a claim with respect to any Notes
issued under
the
Indenture that are payable in a foreign or
composite currency (or a
foreign or
composite currency judgment in respect of such claim) be
converted into U.S.
dollars at a rate of
exchange prevailing on a date
determined pursuant to
applicable
law or by governmental authority to
limit, delay or
prohibit the making of payments outside the United States;
the
Notes have been duly authorized by such Issuing Trust for offer,
sale,
issuance and
delivery pursuant to this Agreement and, when issued,
authenticated and delivered in the manner provided for in the
Indenture and
delivered against
payment of the consideration therefor, will constitute
valid and legally
binding obligations of
such Issuing Trust,
enforceable
against such
Issuing Trust in accordance with their terms, except as
enforcement
thereof may
be limited by bankruptcy, insolvency,
reorganization,
moratorium or other similar laws affecting the enforcement
of
creditors'
rights generally or by general equitable principles
(regardless of whether
enforcement is considered in a proceeding in equity
or
at law); the Notes will be substantially in a form previously
certified
to
the Agents and
contemplated by the Indenture; and each holder of Notes
will
be entitled to the benefits set forth in the Indenture.
(iv) Absence of Defaults and Conflicts. Such Issuing Trust is not in
violation of its
certificate of trust or in default in the performance or
observance of any obligation, agreement, covenant or condition
contained in
any
contract, indenture, mortgage, loan or credit agreement, note,
lease or
other agreement or
instrument to which such Issuing Trust is a party or by
which it may be bound or to which any of the property or assets of such
Issuing Trust is subject (the "Issuing Trust Agreements and
Instruments"),
except for such
violations or defaults that would not result in an Issuing
Trust Material Adverse Effect; and the execution, delivery and performance
of
this Agreement, the Issuing Trust Agreement, the Issuing Trust
Administration
Agreement, its
Notes and the Indenture and any other
agreement or
instrument
entered into or issued or to be entered
into or
issued by such Issuing Trust in connection with the transactions
contemplated by the
Time of Sale Prospectus, the consummation of the
transactions
contemplated in the
Time of Sale
Prospectus (including
the
issuance and sale of the Notes by an Issuing Trust and the use of proceeds
therefrom as described in the Time of Sale Prospectus) (collectively, the
"Issuing Trust Program Documents") and the compliance by such
Issuing Trust
with
its obligations hereunder and under the Issuing Trust Program
Documents, have been duly authorized by all necessary action and do
not and
will
not,
12
<PAGE>
whether with or
without the giving of notice or the
passage of time or
both, conflict
with or constitute a breach of, or default or event or
condition which gives
the holder of any note, debenture or other evidence
of
indebtedness (or any person acting on such holder's behalf) the
right to
require the repurchase, redemption or repayment of all or a portion
of such
indebtedness by such
Issuing Trust under, or result in the creation or
imposition of any lien, charge or encumbrance upon any
assets, properties
or
operations of any
Issuing Trust or such Issuing Trust pursuant to, any
Issuing Trust
Agreements and
Instruments, nor will
such action result in
any
violation of such Issuing Trust's certificate of trust, the Issuing
Trust Agreement or the
Issuing Trust
Administration
Agreement which
may
reasonably be
expected to result in an Issuing
Trust Material Adverse
Effect and such
Issuing Trust is not in default
in the performance or
observance of any applicable law, statute, rule, regulation, judgment,
order, writ or decree
of any government,
government
instrumentality
or
court, domestic or foreign, having jurisdiction over such
Issuing Trust or
any
of its assets, properties or operations, except for such defaults
which
would not reasonably
be expected to result
in an Issuing Trust
Material
Adverse Effect.
(v) Absence of
Proceedings.
There is no action,
suit, proceeding,
inquiry or
investigation before
or brought by any
court or
governmental
agency or body,
domestic or foreign,
now pending, or to the
knowledge of
such
Issuing Trust
threatened,
against or affecting
such Issuing
Trust
which is required to be disclosed in the Registration Statement and the
Base
Prospectus, as amended or supplemented (other than as stated
therein),
or
which may reasonably
be expected to result in an Issuing Trust Material
Adverse Effect;
and the aggregate of all pending
legal or governmental
proceedings to which
such Issuing Trust is
a party or of which any of its
assets, properties or
operations is the subject which are not described in
the
Registration
Statement and the Time of Sale Prospectus, including
ordinary routine litigation incidental to the business,
may not reasonably
be
expected to result in an Issuing Trust Material Adverse Effect.
(vi) Possession of Licenses and Permits. Such Issuing Trust possesses
such
Governmental Licenses issued by the appropriate federal,
state, local
or
foreign regulatory
agencies or bodies necessary to conduct the business
now
operated by it; such Issuing Trust is in compliance with the terms and
conditions of all such Governmental Licenses, except where the failure so
to
comply would not, singly or in the aggregate, result in an Issuing
Trust
Material Adverse Effect; all of the Governmental Licenses are valid and in
full
force and effect,
except where the
invalidity of such
Governmental
Licenses or the failure of such Governmental Licenses to be in full force
and
effect would not result in an Issuing Trust Material Adverse Effect.
Except as otherwise set forth in the Time of Sale Prospectus,
such Issuing
Trust has not received any notice of proceedings relating to the
revocation
or
modification of any such Governmental Licenses which, singly or in the
aggregate, if the
subject of an unfavorable decision, ruling or finding,
would result in an Issuing Trust Material Adverse Effect.
(vii) No Filings,
Regulatory Approvals
etc. Other than the filing of
the
applicable financing
statements, if any, no
filing with, or approval,
authorization,
consent, license,
registration,
qualification,
order or
decree of, any court or governmental authority or agency, domestic or
foreign, is necessary or required for the due authorization,
execution and
delivery by such Issuing Trust of the Issuing Trust Program
13
<PAGE>
Documents or for the performance by such Issuing Trust of the
transactions
contemplated in the
Issuing Trust Program
Documents, except such
as have
been
previously made, obtained or rendered, as applicable.
(viii) Investment Company Act. Such Issuing Trust is not, and upon
any
sale
of Notes by such Issuing Trust as herein contemplated and the
application of the net proceeds therefrom as described in the Time
of Sale
Prospectus will not
be, an "investment
company" within the meaning of the
1940
Act.
(ix) Notes Listed on
any Stock Exchange.
If specified in a Pricing
Supplement, such Issuing Trust's Notes described in such Pricing
Supplement
shall be listed
on the securities exchange designated in the Pricing
Supplement.
(c)
Additional Certifications. Any certificate signed by any officer of
the
Global Funding Delaware Trustee, on behalf of Global Funding or any
officer of
the Delaware Issuing
Trustee, on behalf of the applicable
Issuing Trust, and
delivered to one or more Agents or to counsel for the Agents in
connection with
an offering of Notes to one or more Agents as principal or through an Agent as
agent shall be deemed a representation and warranty by Global
Funding or Issuing
Trust (as applicable)
to such Agent(s) as to the matters covered thereby on the
date of such certificate and, unless subsequently amended or supplemented,
at
each Representation Date subsequent thereto.
SECTION 3. Purchases as Principal; Solicitations as Agent; Other
Sales.
(a)
Purchases as Principal. Notes purchased from an Issuing Trust by the
Agents, individually or in a syndicate, as principal shall be made
in accordance
with terms agreed upon between such Agent(s), on one hand, and Global Funding
and such Issuing Trust, on the other hand, specified in the Terms
Agreement. An
Agent's commitment to
purchase Notes as principal shall be deemed to have been
made on the basis of the representations and warranties of Global Funding
and
Issuing Trust herein
contained and shall be subject to the terms and conditions
herein set forth.
Unless the context otherwise requires, references herein to
"this Agreement"
shall include the
applicable Terms Agreement Each purchase of
Notes by Merrill Lynch, Pierce, Fenner & Smith Incorporated,
as the Purchasing
Agent, unless otherwise agreed, shall be at a discount from the
principal amount
of each such Note equivalent to the applicable commission set forth in
Schedule
2 hereto. Any other
purchase of Notes,
unless otherwise agreed, shall be at a
discount from
the principal amount of each such Note equivalent to the
applicable commission
set forth in Schedule 3 hereto. The Agents may engage the
services of any
broker or dealer in
connection
with the resale of the Notes
purchased by them as principal and may allow all or any portion
of the discount
received by them in connection with such purchases to any broker or
dealer.
If
Global Funding
and an Issuing Trust, on one hand, and two or more
Agents, on the other
hand, enter into a Terms Agreement pursuant to which such
Agents agree to purchase Notes from such Issuing
Trust as principal and
one or
more of such Agents
shall fail at the
Settlement Date to
purchase the Notes
which it or they are obligated to purchase (the "Defaulted Notes"), then the
nondefaulting Agents
shall have the right, within 24 hours thereafter, to make
arrangements for one
of them or one or more
other Agents or
underwriters
to
purchase all, but not less than all, of the
14
<PAGE>
Defaulted Notes in
such amounts as may be agreed upon and upon the terms herein
set forth; provided,
however, that if such arrangements shall not have been
completed within such 24-hour period, then:
(i) if the aggregate
principal amount of Defaulted Notes does not
exceed 10% of the aggregate principal amount of Notes to be so
purchased by
all
of such Agents on the Settlement Date, the nondefaulting Agents shall
be
obligated,
severally and not jointly, to purchase the full amount
thereof in the
proportions that
their respective initial underwriting
obligations bear
to the underwriting obligations of all nondefaulting
Agents; or
(ii) if the aggregate
principal amount of Defaulted Notes exceeds 10%
of
the aggregate
principal amount of Notes to be so
purchased by all
of
such
Agents on the Settlement Date, such agreement shall terminate
without
liability on the part of any nondefaulting Agent.
No
action taken pursuant
to this paragraph
shall relieve any
defaulting
Agent from liability in respect of its default. In the event of any
such default
which does not result
in a termination
of such Terms Agreement, either the
nondefaulting Agents,
on one hand, or Global Funding and such Issuing Trust, on
the other hand,
shall have the right
to postpone
the Settlement Date for a
period not exceeding
seven days in order to effect any required changes in the
Registration Statement, the Time of Sale Prospectus or the
Prospectus or in any
other documents or arrangements.
(b)
Solicitations
as Agent. On the basis of the representations and
warranties herein contained, but subject to the terms and
conditions herein set
forth, when agreed by
an Issuing Trust, on one hand, and an Agent, on the other
hand, such Agent, as an agent of the such Issuing Trust, will use
its reasonable
efforts to solicit
offers for the purchase of such Issuing Trust's Notes upon
the terms set forth in the Registration Statement. Unless the context otherwise
requires, references
herein to "this
Agreement"
shall include the
applicable
Terms Agreement. Such
Agent is authorized to appoint any sub-agent with respect
to solicitations of offers to purchase Notes; provided, however, that any such
appointment of a sub-agent shall be subject to the prior
consent of the Company
and such Issuing Trust. All Notes sold through such Agent
as agent will be sold
at one hundred percent (100%) of their principal amount unless otherwise agreed
upon between the relevant Issuing Trust, on one hand, and such Agent, on the
other hand.
An
Issuing Trust reserves
the right, in its sole
discretion,
to suspend
solicitation of offers
for the purchase of Notes through an Agent, as an agent
of such Issuing Trust, commencing at any time for any period of time or
permanently. As soon
as practicable
after receipt of
instructions
from such
Issuing Trust, such
Agent will suspend
solicitation of offers for the purchase
of Notes issued through such Issuing Trust until such time as such
Issuing Trust
has advised such Agent that such solicitation may be resumed.
Each
Issuing Trust
agrees to pay Merrill
Lynch, Pierce, Fenner & Smith
Incorporated,
for acting
as the Purchasing Agent, as consideration for
soliciting offers to
purchase its Notes as
an agent of such Issuing Trust, a
commission, in the form of a discount, equal to the applicable
percentage of the
principal amount of each Note sold by such Issuing Trust as a
result of any such
solicitation made by the Purchasing Agent, as set forth in Schedule
2 hereto.
15
<PAGE>
Each
Issuing Trust agrees to pay the Agent, as consideration for
soliciting
offers to purchase Notes as an agent of such Issuing Trust, a
commission, in the
form of a discount,
equal to the applicable percentage of the principal
amount
of each Note sold by
such Issuing
Trust as a result of
any such
solicitation
made by such Agent, as set forth in Schedule 3 hereto.
(c)
Administrative
Procedures.
The purchase price, interest rate or
formula, maturity date and other terms of the Notes shall be agreed
upon between
Global Funding and the relevant Issuing Trust, on one hand, and the
applicable
Agent(s), on the other
hand, and specified in a Pricing Supplement prepared in
connection with each
sale of Notes. Except as otherwise specified in the
applicable Pricing Supplement, the Notes will be issued in
denominations of U.S.
$1,000 or any
larger amount that is an integral multiple of U.S. $1,000.
Administrative
procedures with
respect to the
issuance and sale of
the Notes
(the "Administrative
Procedures") shall be
agreed upon from time to time among
Global Funding, the
relevant Issuing Trust, the Agent(s), the relevant Issuing
Trust Administrator
and the Indenture Trustee. The Agents, Global Funding and
each Issuing
Trust agree to perform and Global Funding agrees to cause the
Company, and the
Issuing Trust agrees to cause the Issuing Trust Administrator
and the Indenture
Trustee to agree to
perform, their respective duties and
obligations
specifically provided to be performed by them in the
Administrative
Procedures.
(d)
Obligations Several.
Global Funding and each Issuing Trust acknowledge
that the obligations
of the Agents
under this
Agreement are several and not
joint.
(e)
Other Sales. Subject to the terms and conditions of Sections 1(a),
4(n)
and 4(o), Global
Funding and each
Issuing Trust reserves the right, to be
exercised in their
sole discretion,
to sell Notes of such
Issuing Trust,
in
compliance with all applicable securities laws, to other
investors without
the
assistance of any Agent.
SECTION 4. Covenants of Glo